Komipharm International Market Cap

Komipharm International has a market cap or net worth of 619.25 billion as of June 12, 2026. Its market cap has increased by 58.66% in one year.

Market Cap

619.25B

Enterprise Value

637.44B

Revenue

49.99B

Ranking

n/a

PE Ratio

n/a

Stock Price

8,560.00

Market Cap Chart

Since March 1, 2002, Komipharm International's market cap has increased from 94.26B to 619.25B, an increase of 556.95%. That is a compound annual growth rate of 8.06%.

Market Cap History

Date	Market Cap	% Change
Jun 12, 2026	619.25B	22.15%
Dec 30, 2025	506.94B	89.57%
Dec 30, 2024	267.41B	-9.03%
Dec 28, 2023	293.94B	-34.10%
Dec 29, 2022	446.06B	-18.67%
Dec 30, 2021	548.45B	-36.13%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	59.53T
Celltrion	36.52T
ALTEOGEN	18.59T
Samsung Epis Holdings	10.80T
WON TECH	665.58B
Myung In Pharmaceutical LTD.	632.18B
InBody Co.,Ltd	616.22B
JW Pharmaceutical	604.82B

Market Cap Rankings